Who owns COMPASS THERAPEUTICS INC COM?
- Ticker: CMPX
- CUSIP Number: 20454b104
Tip: Access positions for across all investors
Analyze quarterly positions in Compass Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Compass Therapeutics stock
Who bought or sold COMPASS THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 22M | $44M | 0% | Mar 2024 |
|
| Adage Capital Partners GP | 11M | $22M | 74% | Mar 2024 |
|
| Henderson Group | 6.5M | $13M | -1% | Mar 2024 |
|
| Blackstone Group | 6.2M | $12M | 0% | Mar 2024 |
|
| BlackRock | 6.0M | $12M | 1% | Mar 2024 |
|
| Cormorant Asset Management | 5.6M | $11M | 100% | Mar 2024 |
|
| Rock Springs Capital Management | 5.5M | $11M | 0% | Mar 2024 |
|
| FMR | 4.5M | $8.9M | -1% | Mar 2024 |
|
| Vanguard Group | 4.2M | $8.2M | 2% | Mar 2024 |
|
| Vivo Capital | 3.6M | $7.0M | 0% | Mar 2024 |
|
| Opaleye Management | 3.2M | $6.3M | 100% | Mar 2024 |
|
| Blue Owl Capital Holdings | 2.8M | $5.6M | 0% | Mar 2024 |
|
| Geode Capital Management | 2.1M | $4.1M | 10% | Mar 2024 |
|
| MPM Oncology Impact Management | 2.0M | $3.9M | 100% | Mar 2024 |
|
| Baker Bros. Advisors | 1.6M | $3.1M | 0% | Mar 2024 |
|
| Northern Trust | 767k | $1.5M | -7% | Mar 2024 |
|
| Monashee Investment Management | 500k | $990k | 0% | Mar 2024 |
|
| CM Management | 310k | $614k | 148% | Mar 2024 |
|
| Nuveen Asset Management | 305k | $603k | -23% | Mar 2024 |
|
| Bank of New York Mellon | 253k | $500k | -7% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 241k | $477k | 13% | Mar 2024 |
|
| Charles Schwab Investment Management | 240k | $476k | -2% | Mar 2024 |
|
| Pennant Investors | 199k | $394k | 100% | Mar 2024 |
|
| Millennium Management | 194k | $384k | -61% | Mar 2024 |
|
| Morgan Stanley | 164k | $325k | 159% | Mar 2024 |
|
| Exchange Traded Concepts | 147k | $291k | 123% | Mar 2024 |
|
| Citadel Advisors | 144k | $285k | -13% | Mar 2024 |
|
| Two Sigma Investments | 142k | $281k | -26% | Mar 2024 |
|
| Goldman Sachs Group | 123k | $243k | -41% | Mar 2024 |
|
| Rhumbline Advisers | 120k | $237k | 3% | Mar 2024 |
|
| DAFNA Capital Management | 117k | $231k | 0% | Mar 2024 |
|
| UBS Group | 110k | $218k | 7% | Mar 2024 |
|
| Barclays | 76k | $150k | -40% | Mar 2024 |
|
| Two Sigma Advisers | 59k | $117k | -16% | Mar 2024 |
|
| Squarepoint Ops | 51k | $101k | -43% | Mar 2024 |
|
| National Asset Management | 50k | $99k | 0% | Mar 2024 |
|
| MetLife Investment Advisors | 50k | $78k | 0% | Dec 2023 |
|
| Bank of America Corporation | 45k | $90k | -50% | Mar 2024 |
|
| American International | 45k | $71k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 43k | $85k | -4% | Mar 2024 |
|
| Simplicity Wealth | 40k | $80k | 100% | Mar 2024 |
|
| Bleakley Financial Group | 40k | $80k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 38k | $76k | -38% | Mar 2024 |
|
| New York State Common Retirement Fund | 38k | $75k | 0% | Mar 2024 |
|
| Ing Investment Management | 32k | $64k | -19% | Mar 2024 |
|
| Hsbc Holdings | 32k | $48k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 32k | $63k | 15% | Mar 2024 |
|
| SG Americas Securities | 29k | $57k | -40% | Mar 2024 |
|
| T. Rowe Price Associates | 24k | $48k | 3% | Mar 2024 |
|
| New Capital Management | 21k | $42k | 0% | Mar 2024 |
|
| Jane Street | 21k | $41k | -75% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 18k | $35k | -6% | Mar 2024 |
|
| Citigroup | 17k | $34k | 27% | Mar 2024 |
|
| ProShare Advisors | 16k | $33k | 38% | Mar 2024 |
|
| Alliancebernstein | 14k | $21k | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 11k | $22k | 0% | Mar 2024 |
|
| Principal Financial Group | 11k | $21k | -12% | Mar 2024 |
|
| ADAR1 Capital Management | 10k | $20k | 100% | Mar 2024 |
|
| Victory Capital Management | 10k | $20k | -9% | Mar 2024 |
|
| California State Teachers Retirement System | 9.2k | $18k | -89% | Mar 2024 |
|
| Legal & General Group | 7.9k | $16k | -63% | Mar 2024 |
|
| Summit Investment Advisors | 7.5k | $15k | 0% | Mar 2024 |
|
| Federated Investors | 3.5k | $5.5k | 100% | Dec 2023 |
|
| Amalgamated Bank | 3.1k | $6.0k | -64% | Mar 2024 |
|
| Royal Bank of Canada | 2.1k | $0 | -93% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.1k | $1.7k | -78% | Dec 2023 |
|
| Tower Research Capital | 797.00 | $1.6k | -87% | Mar 2024 |
|
| CWM | 161.00 | $0 | 2% | Mar 2024 |
|
| NISA Investment Advisors | 20.00 | $40.000000 | -69% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 16.00 | $31.000000 | 100% | Mar 2024 |
|
Who sold out of Compass Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Avidity Partners Management | Dec 2023 | 1.6M | $2.5M |
| Foresite Capital Management V | Sep 2023 | 1.2M | $2.5M |
| Prosight Management | Sep 2023 | 935k | $1.8M |
| Braidwell | Dec 2023 | 318k | $496k |
| Element Capital Management | Dec 2023 | 294k | $459k |
| ALPS Advisors | Sep 2023 | 94k | $185k |
| Algert Coldiron Investors | Sep 2023 | 34k | $67k |
| Virtu Financial | Dec 2023 | 28k | $44k |
| Florida State Board of Administration | Dec 2023 | 26k | $39k |
| Verition Fund Management | Sep 2023 | 16k | $31k |
| Wexford Capital | Dec 2023 | 13k | $20k |